9TH EUROPEAN AIDS CONFERENCE (EACS)
1st EACS RESISTANCE & PHARMACOLOGY WORKSHOP

October 25 - 29, 2003 Warsaw, Poland

9.2 Disturbances in Lipid and Glucose Metabolism

F8/3 - FAVOURABLE INCREASES IN HIGH-DENSITY LIPOPROTEIN CHOLESTEROL (HDL-C) CONCENTRATIONS IN CHRONIC HIV-INFECTED THERAPY NAÏVE SUBJECTS RECEIVING 908/R QD IN THE SOLO STUDY
Horban A.1, Staszewski S.2, Walmsley S.3, Pierone G.4, Sexton A.5, Stark T.6
 
(1) Hospital of Infectious Disease, Warsaw, Poland,2 University Clinic Frankfurt/M, Germany,3 University Health Network - Toronto General Hospital, Canada,4 Treasure Coast Infectious Disease Consultants, Florida, USA,5 GlaxoSmithKline R&D RTP, USA,6 GlaxoSmithKline R&D, Greenford, UK
 

Background: Chronic HIV infection is associated with decreases in total cholesterol (TC), low-density lipoprotein cholesterol (LDL-C), and HDL-C. In HIV negative subjects, low HDL-C (<40mg/dL) and high TC/HDL-C ratios are associated with an increased risk for cardiovascular disease. Currently available protease inhibitors (PI) have often been associated with increases in TC and LDL-C but little change in HDL-C.

Method: In SOLO, a 48-week randomised study, 322 subjects received 908/r QD (NFV: 327). Serum samples were collected in fasting state. Dyslipidemia was defined according to the US National Cholesterol Education Programme cut-offs.

Results: At baseline (BL), the mean HDL-C level was 38mg/dL (NFV: 37mg/dL). After starting 908/r QD, mean HDL-C increased over 48 weeks to 46mg/dL (+ 29%; NFV: +27%). TC increased by 38% (NFV: +37%), but with minimal changes in TC/HDL-C ratio (mean +0.39; NFV: +0.34) observed.

  908/r QD (N=232)  908/r QD  NFV BID (N=245)  NFV BID 
Observed Analysis  BL  Wk 48  BL  Wk 48 
% with HDL-C <40mg/dL  60  25  68  31 
% with HDL-C >40mg/dL and < 60mg/dL  36  61  28  51 
% with HDL-C >60mg/dL  4  15  4  18 
% with TC/HDL-C ratio >6.5  15  18  9  14 

Conclusion: In this chronically HIV infected ART-naïve population with low BL HDL-C, substantial increases in HDL-C combined with minimal changes in the TC/HDL-C ratio were observed following treatment with 908/r QD and NFV for 48-weeks. Similar observations were previously reported with NNRTIs.

Presenting Author: Dr. Andrzej Horban, Hospital of Infectious Disease - AIDS Diagnosis and Therapy Center, 37, Wolska Str., PL - 01-, Warsaw, Poland, Phone: ++48-22-6320611

031025
41